Tectonic Therapeutic | AVRO - Pre Tax Profit


Tectonic Therapeutic reported $-18.97M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alnylam Pharmaceuticals USD 221.65M 60.52M Mar/2026
Celltrion KRW 11.84B 1.34B Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
MacroGenics USD -36.77M 21.84M Mar/2026
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Pharma Mar EUR 1.6M 38.6M Mar/2026
Qiagen NV USD 109.17M 25.56M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD 343.17M 750.85M Mar/2026
Sartorius EUR 157.8M 76.1M Mar/2026
Takeda JPY -52.48B 186.34B Mar/2026
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026